Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. - Wikidata - wikimedia - TriplyDB

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

http://www.wikidata.org/entity/Q34328209

about

ATP1A2 Mutations in Migraine: Seeing through the Facets of an Ion Pump onto the Neurobiology of Disease Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?Intracellular Molecular Differences in Aldosterone- Compared to Cortisol-Secreting Adrenal Cortical Adenomas Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential Genetic alterations in primary aldosteronism Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease Neurogenomics in Africa: Perspectives, progress, possibilities and priorities Insights from exome sequencing for endocrine disorders Genetics of Aldosterone-Producing Adenoma in Korean Patients Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Role of voltage-gated calcium channels in the regulation of aldosterone production from zona glomerulosa cells of the adrenal cortex.Overview of the genetic determinants of primary aldosteronism.Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease.Sodium and proton effects on inward proton transport through Na/K pumps.Screening for intellectual disability using high-resolution CMA technology in a retrospective cohort from Central Brazil.Decreased LINE-1 methylation levels in aldosterone-producing adenoma.Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism Uncoupling of secretion from growth in some hormone secretory tissues.A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.The African Genome Variation Project shapes medical genetics in Africa.Vitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma.Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production.Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.Two-pore domain potassium channels in the adrenal cortex.Primary Aldosteronism and ARMC5 Variants.LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

P2860

Q26738318-47F8D5FB-9425-4002-8FA3-A8348F42C43D Q26740687-2F4EC388-3691-4D37-8E94-DA2AC1C5F757 Q26742189-9ACF9681-D33C-44C8-951A-5AEE90C6B5ED Q26742192-8AD6DB9B-537F-4021-9252-CF75643A7F44 Q26745558-2D164A62-0548-4D9A-96BF-B638AAC25FDB Q26781422-3233ABA1-4108-48F4-94E2-18A86D655595 Q26998759-3CF912A6-34B9-4BAC-803E-E308073815E8 Q26998925-DBB525F8-B41C-4F3F-A507-1778C616CD1C Q27006954-E37FE5E3-C872-4DCD-8819-EE0E2580819C Q27007769-6BC336B3-6AB6-48F0-B8E2-172D54E2FF46 Q27011660-3C48B22A-1617-4399-BE83-4C53A88E97DD Q28075329-359A9DBF-1A1E-4900-91E7-B1BFB13C24FD Q28088772-446AC633-FE85-4BA2-8014-198D9F3C93F0 Q28552834-D059EFC5-3DDA-4C68-A504-0CC5B975E8C4 Q30248429-C3FFD275-9CD7-4567-81A3-11BA13BC1939 Q30277613-342EA023-5699-43E3-9788-CFA6FD33259C Q33575337-8A1813DE-7E88-4ED0-A63F-1200F0DDA4A0 Q33579003-322710A5-E328-492B-85F9-6D231ABF376A Q33585059-EA3D4106-E01B-4148-92BA-82800FC42AF5 Q33655764-EF5DF182-6B2C-4523-85A6-B30DE713DE94 Q33766129-2D1A53E4-47BA-4500-BC3F-83968CE78384 Q33803674-C72199E4-81FB-45DC-9A80-EC3335706E4B Q33951754-55FED6A1-720F-4953-B3B9-FA70733E6C5C Q34029143-45C4E5ED-CAA7-4D44-8769-4A2672BD4ED5 Q34310903-8DBAFB7C-5B6E-44CB-B7DB-9E3F03ACF58A Q34361657-220C0D6E-C1BA-4E4B-86F4-C87E5E30AA08 Q34468153-F167FB55-32DF-4FFB-9CA4-982C3ADFAEF7 Q34810955-A9F25819-42AB-4777-84C3-6ADBCFD50D39 Q34850075-8FA6EB37-DB8A-4A0F-B986-4BCD88694F71 Q34979569-B360A05C-0996-4CAD-8A8D-381C9FBFCC1B Q35077564-7ED03FDF-E5AB-46D0-A670-1AD068D79FF0 Q35279380-D95BDB49-888E-46FE-BB45-72E4D99F8993 Q35436012-78E17285-75EC-4CAB-B0DA-500D20DB54B4 Q35534007-730267C4-5F84-4DBA-BD15-1A9D14D1CF2E Q35597757-E6DC8E77-99C7-48F6-841F-EFA6CC267CC8 Q35680827-72025765-A7B8-42F8-80AB-B79D8A2F4E8E Q35680832-E63D22BE-7486-47EB-9072-C644D8212BAA Q35726125-DA9844B8-C8C3-4C6D-9CB9-6071FC8AF145 Q35728142-BC2894FF-BAEF-4B5F-9D35-2D7F1663D405 Q35760982-4E6E63A7-B05D-4A24-BFA2-38C21DD0D6B4

P2860

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

http://www.wikidata.org/entity/Q34328209

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@ast

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@en

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@nl

type

label

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@ast

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@en

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@nl

prefLabel

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@ast

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@en

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@nl

P1433

Q34328209-DD91A517-7770-4E87-B1E2-E984C25B3417

P1476

Q34328209-AD06629A-B911-4C4E-BC9F-4AB22838D3E3

P2093

Q34328209-0B4720D4-B5AC-4FD9-B875-DC294679E776

Q34328209-0B5874ED-8017-4534-986B-0918233EFAEB

Q34328209-1BD79FB1-F3A7-4238-AD25-C45B1325745C

Q34328209-1EFB9A52-540A-4D35-98D1-9AD907034EC5

Q34328209-2F54940C-3D5E-40F5-A9EC-DCEDB901A320

Q34328209-3828BF37-B80C-40BD-A5DE-910CEFB6A62D

Q34328209-407DBED2-0595-4F92-962E-B6F856C9FDBE

Q34328209-42B06317-7565-407C-A442-0CC74A1CD471

Q34328209-5B55426A-AFA0-4156-BB0A-9B4F480591A4

Q34328209-81A3AA57-5298-47B7-891B-CB2F889C6672

P2888

Q34328209-7C26A33B-5752-4A35-B11E-A96D43324046

P304

Q34328209-13A108B6-5FAF-42D9-9883-94769FAB457F

P31

Q34328209-7781B092-EF62-4500-BFF8-37352A98B612

P356

Q34328209-860D9F37-2A4C-4C34-A6C5-6200C4C11685

P407

Q34328209-D84406CE-5A36-4908-A666-F5CAD8D1FED2

P433

Q34328209-E9C27270-96AC-419B-A992-576F85CFAC71

P478

Q34328209-293E7BC2-815D-47A2-8841-62AF4484B967

P50

Q34328209-74B0CAE2-7417-40F6-99FF-BBE748BCF463

Q34328209-8535FB7D-5C13-4DCF-9281-3D473F7E22D1

Q34328209-8C696D90-4F5E-4BA0-967A-C00B3A1740F9

Q34328209-A71E8FB9-CD24-470E-AE77-15AD7D91900B

Q34328209-A875B981-FA13-4516-895F-2E1196488E96

Q34328209-C753A16F-BDCC-4FC5-AF88-7950DCEEF82A

Q34328209-D5D55925-B53E-422E-B54D-84D6AE3511D3

Q34328209-D6582E34-CFCB-4EE2-8013-B03963C0AC2D

Q34328209-E3401AD2-97C5-45A2-94F5-391CFDB1E783

Q34328209-F74E7594-2790-4B47-A851-A7E2181D4C00

P577

Q34328209-6E756323-5358-42D8-85A3-756613827DD1

P698

Q34328209-604CC50A-F85E-43F5-9EA0-7B3662B38CDB

P356

P1433

Nature Genetics

P1476

Somatic mutations in ATP1A1 an ...... as and secondary hypertension.

@en

P2093

Andrea Osswald

http://www.w3.org/2001/XMLSchema#string

Anett Walther

http://www.w3.org/2001/XMLSchema#string

Arndt Benecke

http://www.w3.org/2001/XMLSchema#string

Benoit Samson-Couterie

http://www.w3.org/2001/XMLSchema#string

Bruno Allolio

http://www.w3.org/2001/XMLSchema#string

David Penton

http://www.w3.org/2001/XMLSchema#string

Elisabeth Graf

http://www.w3.org/2001/XMLSchema#string

Evelyn Fischer

http://www.w3.org/2001/XMLSchema#string

Franco Mantero

http://www.w3.org/2001/XMLSchema#string

Hang N Nielsen

http://www.w3.org/2001/XMLSchema#string

P2888

P304

440-4, 444e1-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.2550

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Meitinger

Xavier Jeunemaitre

Felix Beuschlein

Sheerazed Boulkroun

Maria-Christina Zennaro

Marcus Quinkler

Francesco Fallo

P577

2013-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23416519

http://www.w3.org/2001/XMLSchema#string